Pharma Journalist -

EyePoint Pharmaceuticals and Ocumension Therapeutics announced an exclusive license agreement for the development and commercialization of DEXYCU (dexamethasone intraocular suspension)…
Read More...

SMi Reports: On Day One, the main focus points for discussion will be on drug product formulation and control strategies. Sessions include: Challenges and opportunities in…
Read More...

Bionetix, a biotech company developing novel oncology drugs; ProQinase, an oncology-focused contract research organization (CRO) recently acquired by Reaction Biology Corporation…
Read More...

SMi presents Europe's leading 14th annual Parallel Trade conference, taking place in London on the 4th-5th of February 2020. This event provides the platform for industry experts from…
Read More...

Pelican BioThermal announced the further expansion of its worldwide reach into Australia and New Zealand, effective immediately. Wilpak Group International will provide sales and…
Read More...

ATAI Life Sciences AG announced an investment in two separate joint ventures (JV) with DemeRx, a clinical stage pharmaceutical company focused on developing ibogaine and noribogaine for…
Read More...

Genialis announced a collaborative partnership with Oncologie, an international, clinical-stage biopharma developing next-generation immunotherapies for cancer. Initial activities will…
Read More...

Sanofi announced the successful completion of its acquisition of Synthorx, Inc. for $68 per share in cash. “The acquisition of Synthorx perfectly aligns with our R&D strategy,…
Read More...

Evotec SE and Indivumed GmbH announced that the companies have entered into a new research collaboration to discover and develop first-in-class therapeutics for the treatment of…
Read More...

Moderna, Inc. a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, and…
Read More...